Opinion
The drug developed by Alkermes took a lot of flack but proved effective in a recent study.
We write about science every day, why isn’t it getting through to the public consciousness?
Big pharmas are having a good year so far in terms of FDA approvals.
Incyte has been at the forefront of the IDO race with its candidate epacadostat.
Rumor is there’s a new approach to fighting cancer in town.
The former Biogen CEO is making waves at his new venture, Vir Biotechnology.
The drug developed by Nogra always seemed like a longshot, but Celgene management talked it up over the years as it advanced.